The UK life sciences sector is set for a year of progress, driven by new investment, government initiatives, and evolving hiring priorities. Both companies and job seekers need to understand the key trends emerging in the job market.

Pipeline for activity & innovation

• BioNTech plans to invest up to £1 billion in the UK over the next decade, creating R&D hubs in genomics, oncology, and AI-enabled discovery.
• Globally, life sciences firms are focusing on new modalities, large molecules, cell & gene therapies, RNA platforms, and antibody-drug conjugates, as growth drivers over the next 2-3 years.
• Current pharma pipelines include 29 ‘blockbuster assets’ (with $1 billion projected annual revenue), highlighting opportunities for UK innovators.

Investment trends

• UK biotech raised £1.23 billion in VC funding in the first half of 2025, on track to match or exceed 2024 totals.
• A major £1.18 billion acquisition of ViceBio by Sanofi in 2025 shows strong investor confidence in UK innovation.
• However, foreign investment and clinical trial activity in the UK have lagged behind global peers, posing a competitive challenge that could influence where R&D gets funded and executed.

2026 forecast and what’s next?

Government reforms through the NHS and MHRA aim to streamline clinical trial timelines and improve market access, potentially accelerating time to market. Patent expiries on major global drugs are driving big pharma toward acquisitions and external innovation sourcing, especially in AI-driven biotech and precision therapeutics. These trends are creating strong demand for talent, particularly clinical development and regulatory experts, data scientists and AI/bioinformatics specialists, and technical and operational leaders.

What this means for you

For life science companies: 2026 is about prioritising quality over quantity in hiring, the right hires can make the difference between pipeline progress and commercial growth.

For job seekers: Align your skills with in-demand roles, specialist expertise and cross-functional ability will be especially valuable in gaining opportunities across R&D, data-driven science, and operational leadership.